Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cell-Free DNA Methylation as Blood-Based Biomarkers for Pancreatic Adenocarcinoma—A Literature Update

9 Apr 2021

Abstract excerpt

Pancreatic adenocarcinoma has a horrible prognosis, which is partly due to difficulties in diagnosing the disease in an early stage. Additional blood-born biomarkers for pancreatic adenocarcinoma are needed. Epigenetic modifications, as changes in DNA methylation, is a fundamental part of carcinogenesis. The aim of this paper is to do an update on cell-free DNA methylation as blood-based biomarkers for pancreatic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34968295
DOI: 10.3390/epigenomes5020008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cell-Free DNA Methylation as Blood-Based Biomarkers for Pancreatic Adenocarcinoma—A Literature UpdatePMID 34968295Read ↗

Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers’ DiscoverySemantic proximity Read ↗

Deciphering DNA methylation signatures of pancreatic cancer and pancreatitisSemantic proximity Read ↗

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic CancerSemantic proximity Read ↗

Promoter hypermethylation in plasma‐derived cell‐free DNA as a prognostic marker for pancreatic adenocarcinoma stagingSemantic proximity Read ↗

Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic CancerSemantic proximity Read ↗

DNA Hypermethylation as a Blood-Based Marker for Pancreatic Cancer: A Literature Review.Semantic proximity Read ↗

Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinomaSemantic proximity Read ↗

Genome-Wide Analysis of Cell-Free DNA Methylation Profiling for the Early Diagnosis of Pancreatic CancerSemantic proximity Read ↗

Circulating cell-free DNA methylation analysis of pancreatic cancer patients for early noninvasive diagnosisSemantic proximity Read ↗

Cell-free DNA for the detection of pancreatic, liver and upper gastrointestinal cancers: has progress been made?Semantic proximity Read ↗

A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.Semantic proximity Read ↗

Circulating cell‐free <scp>DNA</scp> methylation‐based multi‐omics analysis allows early diagnosis of pancreatic ductal adenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.